{
  "abstract": "High immune-cell infiltration does not guarantee effective anti-tumor immunity. Suppression of anti-tumor immunity may explain the variable prognosis and immunotherapy response of immune-inflamed triple-negative breast cancer (TNBC). We asked whether suppression-associated transcriptional signals merely accompanied effector-rich infiltration or retained a distinct association with TNBC across cohorts. Across TCGA-BRCA (discovery, n = 728), METABRIC (replication, n = 1980), and a Saudi exploratory cohort (n = 38), we evaluated a predefined effector immunity composite, an immunoregulatory cell-enrichment composite, and a six-gene suppressive myeloid-associated transcriptional score (CSF3R, OLR1, C5AR1, CLEC4E, ARG2, S100A8). In TCGA-BRCA, the effector immunity composite and six-gene score were both elevated and co-varied strongly (Spearman ρ = 0.66). Notably, the six-gene score remained associated with TNBC after adjustment for effector enrichment and age. The immunoregulatory cell-enrichment composite showed no significant difference, with opposing shifts among its components. In METABRIC, the main findings replicated and all three programs were elevated; the Saudi cohort showed concordant elevation. In a post hoc joint model with all three programs and age, the six-gene score remained positively associated with TNBC in TCGA-BRCA (OR 2.37) and METABRIC (OR 1.27). The six-gene score thus captured reproducible TNBC-associated variation beyond effector enrichment. Our findings motivate investigating whether this myeloid–effector interplay relates to TNBC prognosis and therapy response.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Faisal University, Al-Ahsa 36362, Saudi Arabia",
    "Research Center, King Fahad Specialist Hospital–Dammam, Eastern Health Cluster, Dammam 32253, Saudi Arabia"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 2,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Shorog Al Omair",
      "orcid": "0000-0003-2474-7638"
    },
    {
      "affs": [
        1
      ],
      "name": "Fahad Almsned",
      "orcid": "0000-0003-3421-1394"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/dn3xf93esftpq.bib",
  "cited_by": 0,
  "doi": "10.3390/ijms272210208",
  "fulltext_url": null,
  "id": "dn3xf93esftpq",
  "issns": [
    "1422-0067"
  ],
  "landing_url": "https://www.mdpi.com/1422-0067/27/22/10208",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-14",
  "publisher": "MDPI AG",
  "ris": "https://research.draconitic.com/paper/dn3xf93esftpq.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:24:18Z",
      "native_id": "10.3390/ijms272210208",
      "source": "crossref",
      "url": "https://www.mdpi.com/1422-0067/27/22/10208"
    }
  ],
  "subjects": [
    {
      "field": "biochemistry",
      "origin": "issn:1422-0067",
      "subfield": "general"
    }
  ],
  "title": "Suppression-Associated Immune Programs in Triple-Negative Breast Cancer Beyond Effector Enrichment: A Multi-Cohort Transcriptomic Analysis",
  "title_text": "Suppression-Associated Immune Programs in Triple-Negative Breast Cancer Beyond Effector Enrichment: A Multi-Cohort Transcriptomic Analysis",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:24:18Z",
  "url": "https://research.draconitic.com/paper/dn3xf93esftpq",
  "venue": "International Journal of Molecular Sciences",
  "versions": []
}